FI63391C - Analogifoerfarande foer framstaellning av nya hentriakontapeptider med opiat-agonist-aktivitet - Google Patents

Analogifoerfarande foer framstaellning av nya hentriakontapeptider med opiat-agonist-aktivitet Download PDF

Info

Publication number
FI63391C
FI63391C FI770835A FI770835A FI63391C FI 63391 C FI63391 C FI 63391C FI 770835 A FI770835 A FI 770835A FI 770835 A FI770835 A FI 770835A FI 63391 C FI63391 C FI 63391C
Authority
FI
Finland
Prior art keywords
lys
gly
thr
obr
boc
Prior art date
Application number
FI770835A
Other languages
English (en)
Finnish (fi)
Other versions
FI770835A (tr
FI63391B (fi
Inventor
Choh Hao Li
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI770835A publication Critical patent/FI770835A/fi
Application granted granted Critical
Publication of FI63391B publication Critical patent/FI63391B/fi
Publication of FI63391C publication Critical patent/FI63391C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/675Beta-endorphins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/28Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI770835A 1976-03-17 1977-03-16 Analogifoerfarande foer framstaellning av nya hentriakontapeptider med opiat-agonist-aktivitet FI63391C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/667,747 US4038222A (en) 1976-03-17 1976-03-17 Untriakontapeptide with opiate activity
US66774776 1976-03-17

Publications (3)

Publication Number Publication Date
FI770835A FI770835A (tr) 1977-09-18
FI63391B FI63391B (fi) 1983-02-28
FI63391C true FI63391C (fi) 1983-06-10

Family

ID=24679466

Family Applications (1)

Application Number Title Priority Date Filing Date
FI770835A FI63391C (fi) 1976-03-17 1977-03-16 Analogifoerfarande foer framstaellning av nya hentriakontapeptider med opiat-agonist-aktivitet

Country Status (26)

Country Link
US (2) US4038222A (tr)
JP (1) JPS52113958A (tr)
AR (2) AR222778A1 (tr)
AT (1) AT355238B (tr)
AU (1) AU514499B2 (tr)
BE (1) BE852510A (tr)
CA (1) CA1092602A (tr)
CH (1) CH625785A5 (tr)
DE (1) DE2711487C2 (tr)
DK (1) DK149203C (tr)
ES (2) ES456901A1 (tr)
FI (1) FI63391C (tr)
FR (1) FR2348912A1 (tr)
GB (1) GB1563654A (tr)
GR (1) GR63092B (tr)
IE (1) IE44226B1 (tr)
IL (1) IL51660A (tr)
LU (1) LU76963A1 (tr)
MC (1) MC1137A1 (tr)
NL (1) NL7702849A (tr)
NO (1) NO147105C (tr)
NZ (1) NZ183605A (tr)
PH (1) PH13864A (tr)
PT (1) PT66311B (tr)
SE (1) SE436354B (tr)
ZA (1) ZA771593B (tr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123523A (en) * 1976-06-21 1978-10-31 Imperial Chemical Industries Limited Analgesic and sedative polypeptides
US4320117A (en) * 1976-06-21 1982-03-16 Imperial Chemical Industries Limited Polypeptide
US4371463A (en) * 1977-02-17 1983-02-01 The United States Of America As Represented By The Department Of Health And Human Services Enzyme-resistant opiate pentapeptides
US4098781A (en) * 1977-03-11 1978-07-04 American Home Products Corporation Polypeptides with morphine-like activity
US4317770A (en) * 1977-03-11 1982-03-02 Hoffmann-La Roche Inc. D-amino acid analogs of beta-endorphin
US4081434A (en) * 1977-03-11 1978-03-28 Hoffmann-La Roche Inc. Novel analogs of β-endorphin
US4127530A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel heneicosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said heneicosapeptides
US4127526A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel tetradecapeptides, intermediates therefor, and compositions and methods employing said tetradecapeptides
US4127522A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel triacontapeptides, intermediates therefor and pharmaceutical compositions and methods employing said triacontapeptides
US4127534A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel tripeptides, intermediates therefor and pharmaceutical compositions and methods employing said tripeptides
US4127540A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel derivatives of δ-endorphins, intermediates therefor, and compositions and methods employing said derivatives
US4139504A (en) * 1977-06-16 1979-02-13 Coy David Howard Novel nonapeptides, intermediates therefor, and compositions and methods employing said nonapeptides
US4127528A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel derivatives of alpha-endorphin, intermediates therefor and compositions and methods employing said derivatives
US4127541A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel decapeptides, intermediates therefor, and compositions and methods employing said decapeptides
US4127523A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel undecapeptides, intermediates therefor, and compositions and methods employing said undecapeptides
US4127539A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel hexacosapeptides, intermediates therefore and pharmaceutical compositions and methods employing said hexacosapeptides
US4127524A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel dodecapeptides, intermediates therefor, and compositions and methods employing said dodecapeptides
ZA783287B (en) * 1977-06-16 1980-01-30 D Coy Novel polypeptides
US4127535A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel dipeptides, intermediates therefor, and compositions and methods employing said dipeptides
US4127533A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel octapeptides, intermediates therefor, and compositions and methods employing said octapeptides
US4312857A (en) * 1977-06-16 1982-01-26 The United States Of America As Represented By The Veterans Administration Novel derivatives of beta-endorphin, intermediates therefor and compositions and methods employing said derivatives
US4127521A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel octacosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said octacosapeptides
US4127536A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel tricosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said tricosapeptides
US4127525A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel tridecapeptides, intermediates therefor, and compositions and methods employing said tridecapeptides
US4127529A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel eicosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said eicosapeptides
US4127538A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel pentacosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said pentacosapeptides
US4127531A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel hexapeptides, intermediates therefor, and compositions and methods employing said hexapeptides
US4127520A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel nonadecapeptides, intermediates therefor, and compositions and methods employing said nonadecapeptides
US4127518A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel derivatives of gamma-endorphins, intermediates therefor, and compositions and methods employing said derivatives
US4127537A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel tetracosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said tetracosapeptides
US4127517A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel docosapeptides, intermediates therefore and pharmaceutical compositions and methods employing said docosapeptides
US4127519A (en) * 1977-06-16 1978-11-28 Coy David Howard Octadecapeptides, intermediates therefor, and compositions and methods employing said octadecapeptides
US4127527A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel pentadecapeptides, intermediates therefor, and compositions and methods employing said pentadecapeptides
US4127532A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel heptapeptides, intermediates therefor, and compositions and methods employing said heptapeptides
US4105652A (en) * 1977-08-05 1978-08-08 Hoffmann-La Roche Inc. Synthesis of human β-endorphin
US4232008A (en) * 1978-11-17 1980-11-04 Ortho Pharmaceutical Corporation Tetrapeptides and methods
US4116950A (en) * 1978-01-16 1978-09-26 Hoffmann-La Roche Inc. Analogs of human β-endorphin
US4330465A (en) * 1978-03-02 1982-05-18 Hoffmann-La Roche Inc. Novel β-endorphin analogs
US4219468A (en) * 1978-11-13 1980-08-26 Hoffmann-La Roche Inc. Tritiated β-endorphin
US4396606A (en) 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
US4250087A (en) * 1979-12-10 1981-02-10 Hoffmann-La Roche Inc. Carboxyl terminus analogs of β-endorphin
JPS56108750A (en) * 1980-02-01 1981-08-28 Takeda Chem Ind Ltd Polypeptide and its preparation
US4438104A (en) 1980-01-03 1984-03-20 Endorphin, Inc. Endorphins having placental or pancreatic origin
US4316895A (en) * 1980-01-03 1982-02-23 Kimball Charles D Endorphins having placental or pancreatic origin
US4350764A (en) * 1980-03-10 1982-09-21 The Regents Of The University Of California Microbiological synthesis of beta endorphin
US4313937A (en) * 1980-08-12 1982-02-02 Tsutomu Oyama Method for producing long-lasting analgesic effects of β-endorphin
DE3152892T1 (de) * 1981-06-16 1983-09-08 John C. 98199 Seattle Wash. Houck Aus placenta oder pancreas gewonnene endorphine
FR2857873B1 (fr) * 2003-07-21 2006-02-24 Courtage Et De Diffusion Codif Procede et produit cosmetique destines a limiter la croissance des tissus adipeux

Also Published As

Publication number Publication date
IL51660A (en) 1980-02-29
ZA771593B (en) 1978-01-25
GB1563654A (en) 1980-03-26
AR222778A1 (es) 1981-06-30
FI770835A (tr) 1977-09-18
PT66311B (en) 1979-01-17
IE44226L (en) 1977-09-17
DE2711487A1 (de) 1977-09-22
ES467453A1 (es) 1978-10-16
SE436354B (sv) 1984-12-03
FR2348912A1 (fr) 1977-11-18
IL51660A0 (en) 1977-05-31
AU514499B2 (en) 1981-02-12
GR63092B (en) 1979-08-13
NO147105C (no) 1983-02-02
NL7702849A (nl) 1977-09-20
BE852510A (fr) 1977-09-16
DK116177A (da) 1977-09-18
PT66311A (en) 1977-04-01
DE2711487C2 (de) 1986-12-11
ES456901A1 (es) 1978-07-16
CH625785A5 (tr) 1981-10-15
AU2329877A (en) 1978-09-21
AT355238B (de) 1980-02-25
US4038222A (en) 1977-07-26
IE44226B1 (en) 1981-09-09
NO147105B (no) 1982-10-25
ATA178877A (de) 1979-07-15
SE7703004L (sv) 1977-09-18
PH13864A (en) 1980-10-22
CA1092602A (en) 1980-12-30
JPS52113958A (en) 1977-09-24
DK149203C (da) 1986-08-04
NO770941L (no) 1977-09-20
USRE29842E (en) 1978-11-21
DK149203B (da) 1986-03-10
FR2348912B1 (tr) 1981-02-13
LU76963A1 (tr) 1978-06-01
AR222007A1 (es) 1981-04-15
JPS62159B2 (tr) 1987-01-06
MC1137A1 (fr) 1977-11-18
FI63391B (fi) 1983-02-28
NZ183605A (en) 1980-02-21

Similar Documents

Publication Publication Date Title
FI63391C (fi) Analogifoerfarande foer framstaellning av nya hentriakontapeptider med opiat-agonist-aktivitet
FI92325B (fi) Menetelmä tymopentiinianalogien valmistamiseksi
Han et al. Studies on the Primary Structure of Bovine High-MolecularWeight Kininogen: Amino Acid Sequence of a Fragment (“Histidine-Rich Peptide”) Released by Plasma Kallikrein
Cody et al. Cyclic melanotropins. 9. 7-D-Phenylalanine analogues of the active-site sequence
EP0561412A1 (en) Parathyroid hormone derivatives
JPH0684400B2 (ja) 新規な生長ホルモン遊離ペプチド
US4081434A (en) Novel analogs of β-endorphin
US4537716A (en) Des-serine2 or des-glycine2 -leucine22 calcitonin
EP0315687B1 (en) (n-alpha-acyl, 8-glycine, des-19-leucine)-calcitonin
US4414149A (en) Glycine8 -D-arginine24 calcitonin
Kasper et al. Subtilisin BPN': III. ISOLATION AND SEQUENCE OF 10 PEPTIDES FROM THE TRYPTIC DIGEST
Kopeyan et al. Amino‐Acid Sequence of Toxin III of Naja haje
Lai et al. Primary structure of cholera toxin subunit A1: isolation, partial sequences and alignment of the BrCN fragments
TZOUGRAKI et al. SYNTHESIS OF HUMAN β‐ENDORPHIN IN SOLUTION USING BENZYL‐TYPE SIDE CHAIN PROTECTIVE GROUPS
CA1248089A (en) Analgesic peptide and process for the preparation thereof
EP0478775B1 (en) Peptide derivatives
US4820804A (en) Analogs of [1,7-di-alanine, des-19-leucine]calcitonin
KR810000736B1 (ko) 헨트리아콘타 펩타이드 유도체의 제조방법
Li et al. β-endorphin: Replacement of glutamic acid in position 8 by glutamine increases analgesic potency and opiate receptor-binding activity
US4639509A (en) [16,19-Di-alanine] calcitonin
Chandramouli et al. Solid phase synthesis of thymosin β9
CA1108122A (en) Protected coupled hentriakontapeptide intermediates
US4824936A (en) (19-Alanine) calcitonin
US4469632A (en) D-Arginine24 calcitonin
EP0287997A2 (en) Des-19-leucine, 20-glutamine, 21-threonine-calcitonin

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: THE REGENTS OF THE UNIVERSITY OF